Forte Biosciences (FBRX) Revenue (2017 - 2019)

Forte Biosciences (FBRX) reported Revenue of $9000.0 for Q4 2019, little changed year-over-year from $9000.0 in Q4 2018, and little changed quarter-over-quarter from $9000.0 in Q3 2019.

Forte Biosciences (FBRX) Revenue (2017 - 2019) Analysis & Trends

Forte Biosciences (FBRX) has 3 years of Revenue data on file, last reported at $9000.0 in Q4 2019.

  • Revenue for Q4 2019 came in at $9000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2019 was $36000.0 (down 99.8% YoY), and the FY2019 annual result was $36000.0, down 99.8% from the prior year.
  • Revenue steadied at $9000.0 in Q4 2019 per FBRX's latest filing, from $9000.0 in the prior quarter.
  • Over five years, Revenue peaked at $18.0 million in Q3 2018 and troughed at $9000.0 in Q1 2018.
  • A 3-year average of $1.6 million and a median of $9000.0 in 2018 frame the typical range for Revenue.
  • The sharpest annual moves came in 2018 and 2019: Revenue jumped 179990.0% in 2018, then slumped 99.95% in 2019.
  • A 3-year view of Revenue shows it stood at $10000.0 in 2017, then dropped by 10.0% to $9000.0 in 2018, then changed by 0.0% to $9000.0 in 2019.
  • Business Quant data shows FBRX's Revenue at $9000.0 in Q4 2019, $9000.0 in Q3 2019, and $9000.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Forte Biosciences 70.77 Mn 12.55 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 9,000.00
Sep 30, 2019 9,000.00
Jun 30, 2019 9,000.00
Mar 31, 2019 9,000.00
Dec 31, 2018 9,000.00
Sep 30, 2018 18.01 Mn
Jun 30, 2018 9,000.00
Mar 31, 2018 9,000.00
Dec 31, 2017 10,000.00
Sep 30, 2017 10,000.00
Jun 30, 2017 10,000.00